Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
Publications
Publications
  • Article
  • Health Affairs

Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated

By: Christopher Ody, Lucy Msall, Leemore S. Dafny, David Grabowski and David Cutler
  • Format:Print
ShareBar

Abstract

Medicare’s Hospital Readmissions Reduction Program (HRRP) has been credited with lowering risk-adjusted readmission rates for targeted conditions at general acute care hospitals. However, these reductions appear to be illusory or overstated. This is because a concurrent change in electronic transaction standards allowed hospitals to document a larger number of diagnoses per claim, which had the effect of reducing risk-adjusted patient readmission rates. Prior studies of the HRRP relied upon control groups’ having lower baseline readmission rates, which could falsely create the appearance that readmission rates are changing more in the treatment than in the control group. Accounting for the revised standards reduced the decline in risk-adjusted readmission rates for targeted conditions by 48 percent. After further adjusting for differences in pre-HRRP readmission rates across samples, we found that declines for targeted conditions at general acute care hospitals were statistically indistinguishable from declines in two control samples. Either the HRRP had no effect on readmissions, or it led to a system-wide reduction in readmissions that was roughly half as large as prior estimates have suggested.

Keywords

Readmission Rates; Hospitals; Acute Care Hospitals; Medicare; Myocardial Infarction; Heart Failure; Health Care and Treatment

Citation

Ody, Christopher, Lucy Msall, Leemore S. Dafny, David Grabowski, and David Cutler. "Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have Been Overstated." Health Affairs 38, no. 1 (January 2019): 36–43.
  • Find it at Harvard
  • Purchase

About The Author

Leemore S. Dafny

General Management
→More Publications

More from the Authors

    • August 10, 2023
    • Promarket

    A Conversation on the Draft Merger Guidelines

    By: Cory S. Capps and Leemore Dafny
    • Summer 2023
    • American Journal of Health Economics

    Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?

    By: Eric Barrette, Leemore S. Dafny and Karen Shen
    • April 20, 2023
    • NEJM.org

    Falling Insulin Prices—What Just Happened?

    By: Leemore S. Dafny
More from the Authors
  • A Conversation on the Draft Merger Guidelines By: Cory S. Capps and Leemore Dafny
  • Do Policies to Increase Access to Treatment for Opioid Use Disorder Work? By: Eric Barrette, Leemore S. Dafny and Karen Shen
  • Falling Insulin Prices—What Just Happened? By: Leemore S. Dafny
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College